Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 180239
                    [Title] => Clot-dissolving therapy stops ‘submassive PE’
                    [Summary] => INGELHEIM, Germany – Clinical trial results published last week in the New England Journal of Medicine demonstrated that the clot-dissolving agent alteplase (Actilyse tPA) can prevent the clinical deterioration of patients with submassive pulmonary embolism.


                    [DatePublished] => 2002-10-17 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

GOETTINGEN

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 180239
                    [Title] => Clot-dissolving therapy stops ‘submassive PE’
                    [Summary] => INGELHEIM, Germany – Clinical trial results published last week in the New England Journal of Medicine demonstrated that the clot-dissolving agent alteplase (Actilyse tPA) can prevent the clinical deterioration of patients with submassive pulmonary embolism.


                    [DatePublished] => 2002-10-17 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Clot-dissolving therapy stops ‘submassive PE’

October 17, 2002 - 12:00am

INGELHEIM, Germany – Clinical trial results published last week in the New England Journal of Medicine demonstrated that the clot-dissolving agent alteplase (Actilyse tPA) can prevent the clinical deterioration...

Science and Environment